Sanofi looks to accelerate MS treatment with $3.68 billion acquisition of Principia Biopharma
August 17, 2020 at 07:13 AM EDT
Sanofi Chief Executive Paul Hudson strikes his second biotech deal since taking over at the French drugmaker last year.